Phase
Condition
T-cell Lymphoma
Lymphoproliferative Disorders
Non-hodgkin's Lymphoma
Treatment
IMC-001
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- ENKTL diagnosis;
Histologically confirmed diagnosed with extranodal NK/T-cell lymphoma, nasaltype
At least 1 previous line of systemic therapy
Documented disease progression of last therapy
Adult age(as defined by respective country)
The nature of the study and voluntarily sign an ICF
ECOG 0 or1
Adequate hematologic function, hepatic function, and renal function
Exclusion
Exclusion Criteria:
Previously treated with an anti-PD-L1 or anti-PD-1 antibody
Known presence of symptomatic CNS metastases
Prior allogeneic HSCT or solid organ transplantation
Any active autoimmune disease or a documented history of autoimmune disease
Apparent active or latent TB and known viral infection with hepatitis B virus orhepatitis C virus
Pregnant or lactating
Study Design
Study Description
Connect with a study center
Chonnam National University Hwasun Hospital
Hwasun, Chonnam
Korea, Republic ofSite Not Available
ChungBuk National University Hospital
Cheonju, Chungbuk
Korea, Republic ofSite Not Available
Gyeongsang National University Hospital
Jinju, Gyeongsangnam-do
Korea, Republic ofSite Not Available
Chonnam National University Hwasun Hospital
Gwangju,
Korea, Republic ofSite Not Available
Gachon University Gil Medical Center
Incheon,
Korea, Republic ofSite Not Available
Asan Medical Center
Seoul,
Korea, Republic ofSite Not Available
Samsung Medical Center
Seoul,
Korea, Republic ofSite Not Available
Seoul National University Hospital
Seoul,
Korea, Republic ofSite Not Available
Ulsan University Hospital
Ulsan,
Korea, Republic ofSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.